Cargando…

Association between reduced brain-derived neurotrophic factor concentration & coronary heart disease

BACKGROUND & OBJECTIVES: Brain-derived neurotrophic factor (BDNF) facilitates neuronal survival, differentiation and synaptic connectivity and affects neurotransmission throughout the brain. However, it has also a modulatory role in energy homeostasis, obesity and cardiovascular function. Obesit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sustar, Aleksandra, Perkovic, Matea Nikolac, Erjavec, Gordana Nedic, Strac, Dubravka Svob, Pivac, Nela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798606/ https://www.ncbi.nlm.nih.gov/pubmed/31571628 http://dx.doi.org/10.4103/ijmr.IJMR_1566_17

Ejemplares similares

Theranostic Biomarkers for Schizophrenia
por: Nikolac Perkovic, Matea, et al.
Publicado: (2017)

Genetic Variants of the Brain-Derived Neurotrophic Factor and Metabolic Indices in Veterans With Posttraumatic Stress Disorder
por: Tudor, Lucija, et al.
Publicado: (2018)

The association between HTR1B gene rs13212041 polymorphism and onset of alcohol abuse
por: Svob Strac, Dubravka, et al.
Publicado: (2019)

Epigenetics of Alzheimer’s Disease
por: Nikolac Perkovic, Matea, et al.
Publicado: (2021)

Relationship between Brain-Derived Neurotrophic Factor and Cognitive Decline in Patients with Mild Cognitive Impairment and Dementia
por: Nikolac Perkovic, Matea, et al.
Publicado: (2023)

Short overview on metabolomic approach and redox changes in psychiatric disorders
por: Nedic Erjavec, Gordana, et al.
Publicado: (2017)

SLC6A3, HTR2C and HTR6 Gene Polymorphisms and the Risk of Haloperidol-Induced Parkinsonism
por: Nedic Erjavec, Gordana, et al.
Publicado: (2022)

N-glycomic Profile in Combat Related Post-Traumatic Stress Disorder
por: Tudor, Lucija, et al.
Publicado: (2019)

Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview
por: Svob Strac, Dubravka, et al.
Publicado: (2021)

Genetic and Epigenetic Association of Hepatocyte Nuclear Factor-1α with Glycosylation in Post-Traumatic Stress Disorder
por: Tudor, Lucija, et al.
Publicado: (2022)

The Association of the Polymorphisms in the FUT8-Related Locus with the Plasma Glycosylation in Post-Traumatic Stress Disorder
por: Tudor, Lucija, et al.
Publicado: (2023)

Reduced Platelet MAO-B Activity Is Associated with Psychotic, Positive, and Depressive Symptoms in PTSD
por: Repovecki, Senka, et al.
Publicado: (2022)

The GABA(A) receptor α2 subunit gene (GABRA2) is associated with alcohol-related behavior
por: Švob Štrac, Dubravka, et al.
Publicado: (2012)

Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia
por: Nikolac Perkovic, Matea, et al.
Publicado: (2020)

Detention in Juvenile Correctional Facilities Is Associated with Higher Platelet Monoamine Oxidase B Activity in Males
por: Podobnik, Josip, et al.
Publicado: (2020)

Genotypic and Haplotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Gene Polymorphisms with Particular Clinical Symptoms in Schizophrenia
por: Sagud, Marina, et al.
Publicado: (2023)

Difference in Methylation and Expression of Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Mild Cognitive Impairment
por: Kouter, Katarina, et al.
Publicado: (2023)

Plasma Brain-Derived Neurotrophic Factor (BDNF) Concentration and BDNF/TrkB Gene Polymorphisms in Croatian Adults with Asthma
por: Sreter, Katherina B., et al.
Publicado: (2020)

Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
por: Vuic, Barbara, et al.
Publicado: (2022)

Platelet Serotonin (5-HT) Concentration, Platelet Monoamine Oxidase B (MAO-B) Activity and HTR2A, HTR2C, and MAOB Gene Polymorphisms in Asthma
por: Konjevod, Marcela, et al.
Publicado: (2023)

Haplotypic and Genotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Polymorphisms and Treatment Resistance in Schizophrenia
por: Sagud, Marina, et al.
Publicado: (2018)

Moderating Effects of BDNF Genetic Variants and Smoking on Cognition in PTSD Veterans
por: Nedic Erjavec, Gordana, et al.
Publicado: (2021)

Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms
por: Vuic, Barbara, et al.
Publicado: (2023)

HTR1A, HTR1B, HTR2A, HTR2C and HTR6 Gene Polymorphisms and Extrapyramidal Side Effects in Haloperidol-Treated Patients with Schizophrenia
por: Grubor, Mirko, et al.
Publicado: (2020)

Relationships of Cerebrospinal Fluid Alzheimer’s Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms
por: Babić Leko, Mirjana, et al.
Publicado: (2020)

Serotonin Receptor Gene Polymorphisms Are Associated with Cerebrospinal Fluid, Genetic, and Neuropsychological Biomarkers of Alzheimer’s Disease
por: Babić Leko, Mirjana, et al.
Publicado: (2022)

The involvement of noradrenergic mechanisms in the suppressive effects of diazepam on the hypothalamic-pituitary-adrenal axis activity in female rats
por: Švob Štrac, Dubravka, et al.
Publicado: (2012)

The serotonergic system and cognitive function
por: Švob Štrac, Dubravka, et al.
Publicado: (2016)

Plasma Brain-Derived Neurotrophic Factor Levels in First-Episode and Recurrent Major Depression and before and after Bright Light Therapy in Treatment-Resistant Depression
por: Kosanovic Rajacic, Biljana, et al.
Publicado: (2023)

The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus
por: Bozek, Tomislav, et al.
Publicado: (2017)

Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases
por: Di Giovanni, Giuseppe, et al.
Publicado: (2016)

Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
por: Babić, Mirjana, et al.
Publicado: (2014)

Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs
por: Svob Strac, Dubravka, et al.
Publicado: (2016)

Association of Lipid Peroxidation Product 4-Hydroxynonenal with Post-Traumatic Stress Disorder †
por: Perković, Matea Nikolac, et al.
Publicado: (2021)

The Associations between COMT and MAO-B Genetic Variants with Negative Symptoms in Patients with Schizophrenia
por: Madzarac, Zoran, et al.
Publicado: (2021)

New tools for neuroenhancement – what about neuroethics?
por: Erhardt, Julija, et al.
Publicado: (2016)

Association of MAPT haplotype‐tagging polymorphisms with cerebrospinal fluid biomarkers of Alzheimer's disease: A preliminary study in a Croatian cohort
por: Babić Leko, Mirjana, et al.
Publicado: (2018)

The Associations of Neutrophil–Lymphocyte, Platelet–Lymphocyte, Monocyte–Lymphocyte Ratios and Immune-Inflammation Index with Negative Symptoms in Patients with Schizophrenia
por: Šagud, Marina, et al.
Publicado: (2023)

The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
por: Radosavljevic, Milica, et al.
Publicado: (2023)

Effects of acute and chronic administration of neurosteroid dehydroepiandrosterone sulfate on neuronal excitability in mice
por: Svob Strac, Dubravka, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uahn5v35bono7g11bddv1tpuir